Jean Jacques Bienaime - 04 Oct 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
04 Oct 2023
Net transactions value
+$856
Form type
4
Filing time
12 Dec 2023, 19:55:13 UTC
Previous filing
09 Aug 2023
Next filing
09 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Small acquisition under Rule 16a-6 $856 +10 +0% $85.57 422,742 04 Oct 2023 Direct F1
transaction BMRN Common Stock Award $0 +2,370 +0.56% $0.000000 425,112 01 Dec 2023 Direct F2
holding BMRN Common Stock 247,333 04 Oct 2023 Shares held by Jean-Jacques Bienaime Family Trust
holding BMRN Common Stock 100 04 Oct 2023 Shares held as UTMA custodian for child 1
holding BMRN Common Stock 100 04 Oct 2023 Shares held as UTMA custodian for child 2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's sale of shares at a price of $99.56 on April 10, 2023. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
F2 Restricted stock units granted on December 1, 2023. Price not applicable.